Absorption, Distribution, Metabolism, and Excretion of CKD-732, a Novel Antiangiogenic Fumagillin Derivative, in Rats, Mice, and Dogs
![]() ![]() |
Lee, Ho-Sup
(Chong Kun Dang Research Institute)
Park, Won-Kyu (Chong Kun Dang Research Institute) Son, Hoe-Joo (Chong Kun Dang Research Institute) Lee, Sung-Sook (Chong Kun Dang Research Institute) Kim, Joon-Kyum (Chong Kun Dang Research Institute) Ahn, Soon-Kil (Chong Kun Dang Research Institute) Hong, Chung-Il (Chong Kun Dang Research Institute) Min, Hye-Ki (Doping Control Center, Korea Institute of Science and Technology) Kim, Myung-Soo (Doping Control Center, Korea Institute of Science and Technology) Myung, Seung-Woon (Doping Control Center, Korea Institute of Science and Technology) |
1 | Dipaolo, J., Tarbell, D., and Moore G., Studies on the carcinolytic activity of fumagillin and some of its derivatives. Antibiot. Annu., 541-546 (1958-1959) |
2 | Folkman, J. and Klagsbrun, M., Angiogenic factors. Science, 235,442-447 (1987) DOI PUBMED |
3 | Folkman, J., Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg., 175,409-416 (1972) DOI PUBMED ScienceOn |
4 | Folkman, J., What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer lnst., 82, 4-6 (1990) DOI PUBMED |
5 | Lee, H. S., Kim, H. Y., Sohn, Y. S., Choi, W. K., Son, H. J., Lee, S. S., Myung, S.-W., Kim, J. K., Ahn, S. K., and Hong, C. I., Metabolism and Pharmacokinetic study of CKD-732. American Association for Cancer Research (93rd AACR), 43, 181 (2002) |
6 | Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itoh, F., Ingber, D., and Folkman, J., Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Cammun., 174, 1070-1076(1991) DOI ScienceOn |
7 | Folkman, J., Tumor angiogenesis. Adv. Cancer Res., 43, 175-203 (1985) |
8 | Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348, 555-557 (1990) DOI ScienceOn |
9 | Myung, S. W., Kim, H. Y., Min, H. K., Kim, D. H., Kim, M. S., Cho, H., W., Lee, H. S., Kim, J. K., and Hong, C. I., The identification of in vitro metabolites of CKD-732 by liquid chromatography/tandem mass spectrometry. Rapid Cammun. Mass Spectrom., 16,2048-2053 (2002) DOI ScienceOn |
10 | Placidi, L., Cretton-Scott, E., Eckoff, D., Bynon, S., and Sommadossi, J. P., Metabolic drug interactions between angiogenic inhibitor, TNP-470 and anticancer agents in primary cultured hepatocytes and microsomes, Drug Metab. Dispas., 27, 623-626 (1999) |
11 | Placidi, L., Cretton-Scott, E., De Sousa, G., Rahmani, R., Placidi, M., and Sommadossi, J. P., Disposition and metabolism of the angiogenic moderator O-(chloroacetylcarbamoyl) fumagillol (TNP-470, AGM-1470) in human hepatocytes and tissue micorosomes. Cancer Res., 55, 3036-3042 (1995). PUBMED |
12 | Killough, J., Magill, G., and Smith, R., The treatment of amoebiasis with fumagillin. Science,115, 71-72 (1952) DOI PUBMED |
13 | Park, H. J., Shon, Y. S., Son, H. J., Moon, S. K., Kim, J. G., Kim, J. K., Ahn, S. K., and Hong, C. I., Combination chemotherapy and preliminary toxicity of CKD-732, a novel fumagillin derivative. American Association for Cancer Research (92nd AACR), 42, 87 (2001) |
14 | Placidi, L., Cretton-Scott, E., De Sousa, G., Rahmani, R., Placidi, M. and Sommadossi, J. P., Interspecies variability of TNP-470 metabolism, using primary monkey, rat and dog cultured hepatocytes. Drug Metab. Dispos., 25, 94-99 (1997) |
15 | Brem, H. and Folkman, J., Analysis of experimental anti-angiogenic therapy. J. Pediatr. Surg., 28, 445-450; Discussion 450-451 (1993) DOI ScienceOn |
16 | Cretton-Scott, E., Placidi, L., McClure, H., Anderson, C. D., and Sommadossi, J. P., Pharmacokinetics and metabolism of O-( chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys. Cancer Chemother. Pharmacol., 38, 117-122 (1996) DOI ScienceOn |
![]() |